CSL Names Deborah Waterhouse CEO and Managing Director, Effective Feb. 1, 2027

By Public Technologies
  • CSL appointed Deborah Waterhouse CEO and managing director, effective February 1, 2027.
  • Waterhouse has led ViiV Healthcare since 2017; her background includes leading GSK's US vaccines and primary care businesses.
  • Interim CEO Gordon Naylor will return to his non-executive director role following the transition.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CSL Limited published the original content used to generate this news brief via CNW (Ref. ID: 202610210353CANADANWCANADAPR_C8217) on October 21, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.